MKOR 📈 Matthews International Funds - Overview
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • • Miscellaneous Region
MKOR: South Korean, Stocks, Equities
Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in the common and preferred stocks of companies located in South Korea.
Additional Sources for MKOR ETF
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
MKOR ETF Overview
Market Cap in USD | 54m |
Category | Miscellaneous Region |
TER | 0.79% |
IPO / Inception | 2010-10-29 |
MKOR ETF Ratings
Growth 5y | -46.0% |
Fundamental | - |
Dividend | - |
Rel. Strength Industry | -146 |
Analysts | - |
Fair Price Momentum | 19.09 USD |
Fair Price DCF | - |
MKOR Dividends
No Dividends PaidMKOR Growth Ratios
Growth Correlation 3m | -93.6% |
Growth Correlation 12m | -30.3% |
Growth Correlation 5y | 9.1% |
CAGR 5y | -11.57% |
CAGR/Mean DD 5y | -1.83 |
Sharpe Ratio 12m | -1.06 |
Alpha | -40.43 |
Beta | 0.89 |
Volatility | 16.00% |
Current Volume | 5.7k |
Average Volume 20d | 14.2k |
What is the price of MKOR stocks?
As of December 27, 2024, the stock is trading at USD 21.07 with a total of 5,720 shares traded.
Over the past week, the price has changed by -2.06%, over one month by -7.59%, over three months by -17.15% and over the past year by -12.92%.
As of December 27, 2024, the stock is trading at USD 21.07 with a total of 5,720 shares traded.
Over the past week, the price has changed by -2.06%, over one month by -7.59%, over three months by -17.15% and over the past year by -12.92%.
Is Matthews International Funds a good stock to buy?
Probably not. Based on ValueRay Analyses, Matthews International Funds (NYSE ARCA:MKOR) is currently (December 2024) not a good stock to buy. It has a ValueRay Growth Rating of -46.02 and therefor a somwhat technical negative rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of MKOR as of December 2024 is 19.09. This means that MKOR is currently overvalued and has a potential downside of -9.4%.
Probably not. Based on ValueRay Analyses, Matthews International Funds (NYSE ARCA:MKOR) is currently (December 2024) not a good stock to buy. It has a ValueRay Growth Rating of -46.02 and therefor a somwhat technical negative rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of MKOR as of December 2024 is 19.09. This means that MKOR is currently overvalued and has a potential downside of -9.4%.
Is MKOR a buy, sell or hold?
Matthews International Funds has no consensus analysts rating.
Matthews International Funds has no consensus analysts rating.
What are the forecast for MKOR stock price target?
According to ValueRays Forecast Model, MKOR Matthews International Funds will be worth about 21.2 in December 2025. The stock is currently trading at 21.07. This means that the stock has a potential upside of +0.38%.
According to ValueRays Forecast Model, MKOR Matthews International Funds will be worth about 21.2 in December 2025. The stock is currently trading at 21.07. This means that the stock has a potential upside of +0.38%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 21.2 | 0.4% |